RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5569
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0514200; Gene model (P.falciparum): PF3D7_1030200; Gene product: claudin-like apicomplexan microneme protein, putative (CLAMP)
Details mutation: a mutated clamp gene with two LoxN sites
Transgene
Transgene not Plasmodium: DiCre
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: Not available; Gene product: Not available (see below for more information)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (p230p)
Transgene
Transgene not Plasmodium: Cas9 from Streptococcus pyogenes
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0711900; Gene product: heat shock protein 70 (HSP70)
Insertion locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (p230p)
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (p230p)
Phenotype Asexual bloodstage;
Last modified: 19 October 2024, 23:04
  *RMgm-5569
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-5567
Other information parent lineThe mutant PbCasDiCre-GFP (Rmgm-5567) expresses both DiCre and Cas9. Both genes are introduced into the silent p230p gene locus and are under control of constitutive promoters. In addition, the mutant expresses GFP under control of the constitutive hsp70 promoter. Parasites of this line does not contain a drug-selectable marker cassette.
The mutant parasite was generated by
Name PI/ResearcherDas S, Silvie O
Name Group/DepartmentCentre d’Immunologie et des Maladies Infectieuses, Cimi-Paris
Name Institute1Sorbonne Université, Inserm, CNRS
CityParis
CountryFrance
Name of the mutant parasite
RMgm numberRMgm-5569
Principal nameclampcKO-HA
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageAnalysis of clampcKO-HA merozoites by immunofluorescence using anti-HA antibodies revealed a punctate distribution of the protein which was often predominant at one pole of the parasite, reminiscent of the apical accumulation of the protein
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant contains a mutated clamp gene with two LoxN sites. The clamp open reading frame (ORF) is C-terminally tagged with a 3xHA epitopeI. It also contains a gfp , cas9 and dicre expression cassettes, introduced into the neutral 230p locus (from the parent line PbCasDiCre-GFP; RMgm-5567).

In order to validate the Cas9 and DiCre combination, we used the PbCasDiCre-GFP line (RMgm-5567) to conditionally delete the gene encoding the Claudin-like apicomplexan microneme protein (CLAMP, PBANKA_0514200). A one-step strategy to introduce a first LoxP site inside an artificial intron, as described in P. falciparum, and a second LoxP site immediately downstream of the STOP codon. A triple HA tag was introduced before the STOP codon for C-terminal tagging of CLAMP. Using this strategy, CRE-mediated recombination should result in immediate and complete suppression of CLAMP expression. Two guide RNAs were selected in the clamp locus, in the 5’ and 3’ regions of the coding sequence, respectively, and cloned into a single plasmid containing PbU6 and PfU6 promoters. The donor DNA template carrying a modified clamp gene with an artificial intron taken from the P. berghei slarp gene (PBANKA_0902100) and containing the first LoxP site, a 3xHA tag and a second LoxP site, was provided as a synthetic gene and linearized before transfection.
Following the transfection of PbCasDiCre-GFP parasites with the double sgRNA plasmid targeting clamp and the linearized donor template DNA, integration of the repair construct by double homologous recombination results in the generation of parasites containing a floxed clamp gene with a C-terminal 3xHA tag. Recombinant parasites were selected with pyrimethamine.

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2024.10.14.618196

Protein (function)
Invasion of host cells by apicomplexan parasites such as Toxoplasma and Plasmodium spp requires the sequential secretion of the parasite apical organelles, the micronemes and the rhoptries. The claudin-like apicomplexan microneme protein (CLAMP) is a conserved protein that plays an essential role during invasion in Toxoplasma gondii tachyzoites and Plasmodium falciparum merozoites. Topology predictions indicate structural similarities between CLAMP and the mammalian tight-junction proteins claudin-15 and claudin-19. CLAMP is also expressed in Plasmodium sporozoites, the mosquito transmitted forms of the malaria parasite. CLAMP is essential for Plasmodium blood stage growth and is refractory to conventional gene deletion.

Phenotype
No phenotype different from wild type parasites.
Analysis of clampcKO-HA merozoites by immunofluorescence using anti-HA antibodies revealed a punctate distribution of the protein which was often predominant at one pole of the parasite, reminiscent of the apical accumulation of the protein.

After rapamycin treatment of parasites the clamp gene (and the GFP gene) is excised. See Additional Information below.

Additional information
Conditional deletion of the clamp gene by rapamycin treatment of blood stage parasites resulted in the following phentotype:
Rapamycin-induced excision of clamp reduced parasitaemia to nearly zero in a single cycle (<24 hours), as compared to untreated parasites, in agreement with an essential role for CLAMP in asexual blood stages. To assess the invasive capacity of CLAMP-deficient merozoites, clampcKO merozoites were produced in culture in the presence or absence of rapamycin, and injected intravenously into mice. Following inoculation, untreated merozoites efficiently invaded mouse erythrocytes and established a blood stage infection, as evidenced by flow cytometry, while rapamycin-exposed merozoites failed to invade erythrocytes, as evidenced by the absence of detectable parasitaemia after inoculation into mice.

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0514200
Gene Model P. falciparum ortholog PF3D7_1030200
Gene productclaudin-like apicomplexan microneme protein, putative
Gene product: Alternative nameCLAMP
Details of the genetic modification
Short description of the mutationa mutated clamp gene with two LoxN sites
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationIn order to validate the Cas9 and DiCre combination, we used the PbCasDiCre-GFP line to conditionally delete the gene encoding the Claudin-like apicomplexan microneme protein (CLAMP, PBANKA_0514200). A one-step strategy to introduce a first LoxP site inside an artificial intron, as described in P. falciparum, and a second LoxP site immediately downstream of the STOP codon. A triple HA tag was introduced before the STOP codon for C-terminal tagging of CLAMP. Using this strategy, CRE-mediated recombination should result in immediate and complete suppression of CLAMP expression. Two guide RNAs were selected in the clamp locus, in the 5’ and 3’ regions of the coding sequence, respectively, and cloned into a single plasmid containing PbU6 and PfU6 promoters. The donor DNA template carrying a modified clamp gene with an artificial intron taken from the P. berghei slarp gene (PBANKA_0902100) and containing the first LoxP site, a 3xHA tag and a second LoxP site, was provided as a synthetic gene and linearized before transfection.
Following the transfection of PbCasDiCre-GFP parasites with the double sgRNA plasmid targeting clamp and the linearized donor template DNA, integration of the repair construct by double homologous recombination results in the generation of parasites containing a floxed clamp gene with a C-terminal 3xHA tag. Recombinant parasites were selected with pyrimethamine
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameDiCre
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative namesee below for more information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative namep230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameCas9 from Streptococcus pyogenes
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasiteNo selectable marker
Promoter of the selectable markerN.A.
Selection (positive) procedureN.A.
Selection (negative) procedureN.A.
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0711900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative namep230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative namep230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4